Skip to content

Improving adverse drug reaction reporting through workshops and telephone education in Portugal

Improving adverse drug reaction reporting through workshops and telephone education in Portugal: a cluster randomised trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN33698297
Enrollment
6579
Registered
2011-09-13
Start date
2007-01-01
Completion date
Unknown
Last updated
2015-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Under-reporting adverse drug reactions Injury, Occupational Diseases, Poisoning Complication of surgical and medical care, unspecified

Interventions

We implemented a continuing medical education multifaceted intervention comprising of telephone interviews and workshops. Telephone education consisted of a telephone conversation between the resear

Sponsors

Northern Pharmacosurveillance Unit (Portugal)
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: All National Health System physicians working in the northern region of Portugal

Exclusion criteria

Exclusion criteria: 1. Physicians not involved in any clinical activity (e.g. engaged in administrative tasks, analysis, etc.) 2. Working in substance abuse and rehabilitation centres 3. Working at the regional pharmacosurveillance centre or any department having a specific voluntary adverse drug reaction reporting program and physicians attached to specific hospitals (cancer, maternity, etc)

Design outcomes

Primary

MeasureTime frame
Rate of total notifications per month

Secondary

MeasureTime frame
Rate of serious, unexpected, high-causality and new-drug-related adverse drug reactions per month

Countries

Portugal

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026